期刊文献+

新型磷酸钙复合盖髓材料的体外抑菌作用 被引量:3

In vitro evaluation of antimicrobial activity of new calcium phosphate cement compound for pulp-capping
下载PDF
导出
摘要 目的研究新型磷酸钙复合盖髓材料(CASBi)对常见致龋菌的体外抑菌作用。方法采用琼脂扩散法,通过测量抑菌圈直径大小,研究并比较CASBi与氢氧化钙糊剂、Dycal、自固化磷酸钙骨水泥(CPC)对变形链球菌(Sm)、粘性放线杆菌(Av)及嗜酸乳杆菌(La)的抑菌效果。结果CASBi对三种细菌都有明显的抑菌作用;氢氧化钙糊剂对3种实验菌有一定抑菌作用,但其抑菌环直径明显小于CASBi抑菌环直径(P<0.05);Dycal对变形链球菌无抑菌作用,对粘性放线菌和乳酸杆菌有较轻微的抑菌作用;CPC对3种细菌均无抑菌作用。结论CASBi对致龋菌有较强的抑菌作用。 Objective To evaluate the in vitro antimicrobial activity of new calcium phosphate cement compound-CASBi as a pulp capping agent. Methods The diameters of bacterial inhibition zone of CASBi, calcium hydroxide paste (CHP), Dycal and calcium phosphate cement (CPC) against Streptococcous mutans (Sm), Actinomyces viscosus(Av) and Lactobacillus casei(Lc) were determined by agar diffusion test, respectively. Distilled water served as control. Result CASBi showed significantly better inhibition on the growth of all tested micro-organisms than the others ( P 〈 0.05). CHP showed a little inhibition on the growth of all the micro-organisms. Dycal revealed a little inhibition on the growth of Av and Lc, but not Sm. CPC and distilled water did not show any inhibition on the growth of the micro-organisms. Conclusion CASBi used as pulp-capping agent possessed high inhibition on growth of the three test bacteria.
出处 《口腔医学》 CAS 2008年第6期306-308,共3页 Stomatology
基金 上海市重点(特色)学科资助(T0202) 上海交通大学医学院博士创新基金资助
关键词 抑菌性 盖髓剂 磷酸钙骨水泥 氢氧化钙 泡铋矿 antimicrobial activity pulp-capping agent calcium phosphate cement (CPC) calcium hydroxide,bismutite
  • 相关文献

参考文献7

  • 1Kobayashi N, Ong K, Villarraga M, et al. Histological and mechanical evaluation of self-setting calcium phosphate cements in a sheep vertebral bone void model[ J ]. J Biomed Mater Res A, 2007,81 (4):838- 846.
  • 2Chaung HM, Hong CH, Chiang CP, et al. Comparison of calcium phosphate cement mixture and pure calcium hydroxide as direct pulp - capping agents[J] .J Formos Med Assec, 1996,95(7):545- 550.
  • 3Zhang W,Walboomers XF, Jansen JA. The formation of tertiary dentin after pulp capping with a calcium phosphate cement, loaded with PLGA microparticles containing TGF-beta1[ J ]. J Biomed Mater Res A, 2007, 85A(2) :439 - 444.
  • 4Stratton CW, Warner RR, Coudron PE, et al. Bismuth-mediated disruption of the glycocalyx-cell wall of Helicobacter pylori : uhrastructural evidence for a mechanism of action for bismuth salts [ J ]. J Antimicrob Chemother, 1999,43(5) :659 - 666.
  • 5孙红哲,张丽,司徒嘉怡.含铋类药物的生物化学和药物化学研究进展[J].中国临床药理学杂志,2002,18(4):297-301. 被引量:19
  • 6桑青,韩宝芹,刘万顺,孙明昆.羧甲基壳聚糖铋盐抗大鼠胃溃疡及杀灭幽门螺杆菌作用的研究[J].高技术通讯,2004,14(7):93-96. 被引量:10
  • 7江茂霞,刘剑波,裴传道,乐进秋,刘宁慧,罗玲莉.显影酚醛树脂的实验室及临床研究[J].广东牙病防治,1998,6(1):1-3. 被引量:1

二级参考文献45

  • 1陈双厚 黄霞珍 等.海明愈疡膏抗炎镇痛化腐生肌作用实验研究[J].中药药理与临床,1997,13:86-86.
  • 2[1]Sun H, Sadler PJ. Bismuth antiulcer complexes. Top Biol Inorg Chem, 1999;2:159~185.
  • 3[2]Slikkerveer A, de Wolff FA. Pharmacokinetics and toxicity of bismuth compounds. Med Toxicol Adverse Drug Exp, 1989;4: 303-323.
  • 4[3]Menge H, Gregor M, Brosius B, et al. Pharmacology of bismuth.Eur J Gastroenterol Hepatol 1994, 4(S2): 41~47.
  • 5[4]J.W. Clitherow, United Kingdom Patent GB2220937A, 1990.
  • 6[5]McColm AA, McLaren A, Klinkert G, et al. Ranitidine bismuth citrate: a novel anti-ulcer agent with different physico-chemical characteristics and improved biological activity to a bismuth citrateranitidine admixture. Aliment Pharmacol Therap, 1996; 10:241~250.
  • 7[6]Sadler PJ, Sun H. Ranitidine bismuth citrate. J Chem Soc Dalton Trans, 1995;1395~1401.
  • 8[7]Warren JR, Marshall B, Unidentified curved bacilli on gastric epithelium in active chronic gastritis. Lancet, 1983; i: 1273~1275.
  • 9[8]Blaser MJ Hypotheses on the pathogenesis and natural history of Helicobacterpylori-induced inflammation. Gastroenterology, 1992;102:720~727.
  • 10[9]Mobley HLT, Island MD, Hausinger RP, Molecular biology of microbial urease. Microbiol Rev, 1995;59:451 ~480.

共引文献26

同被引文献61

  • 1苏勤,叶玲,周学东.纳米羟磷灰石/聚酰胺66盖髓的动物实验研究[J].四川大学学报(医学版),2005,36(1):43-45. 被引量:4
  • 2张晶,张琛,刘红岩,侯本祥.五种牙本质粘接剂体外细胞毒性研究[J].北京口腔医学,2006,14(3):173-175. 被引量:4
  • 3李威,卢友光,苏柏华,丁林灿,闫福华.富血小板血浆复合MTA盖髓的组织学观察[J].口腔医学研究,2006,22(5):478-481. 被引量:8
  • 4王晓虹,常江,孙宏晨.硅酸三钙阻塞牙本质小管的实验研究[J].口腔医学研究,2007,23(2):176-178. 被引量:9
  • 5da Slilva LA,de Freitas AC,de Carvulho FK,et al.Direct pulp capping with a self-etching adhesive system:histopatholngic evaluation in dogs' teeth[J].Oral Surg Oral Med Oral Pathol Oral Radiol Ended,2009,108(1):34-40.
  • 6Jaber L,Mascres C,Donohue WB.Reaction of the dental pulp to hydroxyapatite[J].Oral Surg Oral Med Oral Pathol,1992,73 (1):92-98.
  • 7Kim HW,Kim HE,Salih V.Stimulation of osteoblast responses to biomimetic nanocomposites of gelatin hydroxyapatite for tissue engineering scaffolds[J].Biomaterials,2005,26 (25):5221-5230.
  • 8Peters MC,Bresciani E,Barata TJ,et al.In vivo dentin remineralizalion by calcium-phosphate cement[J].J Dent Res,2010,89(3):286-291.
  • 9Boland EJ,MacDougall M,Carnes DL,et al.In vitro cytotoxicity of a remineralizing resin-based calcium phosphate cement[J].Dent Mater,2006,22(4):338-345.
  • 10Dickens SH,Kelly SR,Flaim GM,et al.Dentin adhesion a ndmicroleakage of a resin-based calcium phosphate pulp capping and basing cement[J].Eur J Oral Sci,2004,112 (5):452-457.

引证文献3

二级引证文献10

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部